Ma Kuang Healthcare Holding Limited (TPEX:4139)
23.75
-0.65 (-2.66%)
At close: Feb 11, 2026
TPEX:4139 Revenue
Ma Kuang Healthcare Holding had revenue of 263.60M TWD in the quarter ending September 30, 2025, a decrease of -10.03%. This brings the company's revenue in the last twelve months to 1.10B, down -4.45% year-over-year. In the year 2024, Ma Kuang Healthcare Holding had annual revenue of 1.13B, down -7.21%.
Revenue (ttm)
1.10B
Revenue Growth
-4.45%
P/S Ratio
0.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.13B | -87.85M | -7.21% |
| Dec 31, 2023 | 1.22B | 159.37M | 15.05% |
| Dec 31, 2022 | 1.06B | 99.29M | 10.35% |
| Dec 31, 2021 | 959.45M | 49.21M | 5.41% |
| Dec 31, 2020 | 910.24M | -109.95M | -10.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Anxo Pharmaceutical | 883.22M |
| Prince Pharmaceutical | 798.27M |
| Level Biotechnology | 753.30M |
| Kim Forest Enterprise | 531.58M |
| Mediera | 240.30M |
| Puriblood Medical | 117.35M |